Fidelity Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Fidelity Investments's FBT Position: Q1 2026 in Review
Fidelity Investments increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 102% in Q1 2026, buying an estimated $240K and bringing the position to 2,291 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3161.
Fidelity Investments first reported a position in FBT in Q4 2018 and has held it in 30 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Fidelity Investments held 2,291 shares of First Trust NYSE Arca Biotechnology Index Fund worth $460K as of Q1 2026.
- Fidelity Investments bought 1,159 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $240K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3161 holding.
- Fidelity Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 30 quarters since.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.